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Abstract
Although routinely done, there has been no evaluation of the utility of performing routine cerebrospinal fluid (CSF)
examination in patients with active coccidioidomycosis and high complement fixation (IgG) antibody titers or other risk
factors for disseminated infection. In our review 100% of patients diagnosed with coccidioidal meningitis had at least one
sign or symptom consistent with infection of the central nervous system, headache was present in 100% of those with
meningitis, while no patients without signs/symptoms of CNS infection were found to have coccidioidal meningitis,
irrespective of antibody titers or other risk factors. Thus routine lumbar puncture may be unnecessary for patients with
coccidioidomycosis who lack suggestive clinical symptoms.
Citation: Thompson G III, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, et al. (2013) Routine CSF Analysis in Coccidioidomycosis Is Not Required. PLoS
ONE 8(5): e64249. doi:10.1371/journal.pone.0064249
Editor: Chaoyang Xue, University of Medicine & Dentistry of New Jersey - New Jersey Medical School, United States of America
Received March 6, 2013; Accepted April 10, 2013; Published May 22, 2013
Copyright:  2013 Thompson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding for this study was generously provided by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: Funding for this study was generously provided by Pfizer. This does not alter the authors’ adherence to all the PLOS ONE policies on
sharing data and materials.
* E-mail: grthompson@ucdavis.edu (GT); bspellberg@LABioMed.org (BS)
Introduction
Coccidioidomycosis refers to the spectrum of disease caused by
the dimorphic fungi Coccidioides immitis and Coccidioides posadasii.
Over 150,000 patients are infected yearly and the incidence
continues to increase [1,2]. Pulmonary infection is the most
common clinical manifestation, however the spectrum of disease
ranges from asymptomatic exposure with subsequent immunity, to
severe and life-threatening disseminated disease [1,3].
Serum coccidioidal complement fixation (CF) titers greater than
1:16 are predictive of an increased likelihood of disseminated
infection [4,5], and although skin and osteomyelitis/synovitis are
the most common manifestations of dissemination, meningitis
remains the most feared complication – occurring in nearly half of
all patients with extrapulmonary coccidioidomycosis [6,7]. Unfor-
tunately, no data are available to determine the frequency of
clinically silent central nervous system (CNS) involvement. Thus,
lumbar puncture (LP) with cerebrospinal fluid (CSF) analysis is
often performed on patients with high CF titers or other risk
factors for meningitis even in the absence of CNS symptoms.
The rationale for this practice is based on the high morbidity
observed in coccidioidal meningitis, the need for life-long
antifungal therapy if coccidioidal meningitis is diagnosed, and
the potential for earlier diagnosis to potentially avoid untoward
outcomes [8]. However, it remains unclear how commonly
patients with CNS coccidioidomycosis present without relevant
symptoms, and anecdotally we have found routine LPs unhelpful
in the absence of patient symptoms compatible with infection of
the CNS. Since this practice subjects patients to potentially
harmful and unneeded diagnostic testing, we sought to determine
the utility of this approach in both patients with and without CNS
symptoms in a multi-center, retrospective study.
Materials and Methods
This study was approved by the Institutional Review Board of
UC-Davis, UC-San Francisco, Harbor-UCLA, UC-San Diego,
and UT-San Antonio. A waiver of consent was granted given the
retrospective nature of the project. Cases were identified by
searching hospital databases from 2005–2010 for ICD9-CM codes
114.0–114.9. Patient charts were manually reviewed and all
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patients with proven coccidioidomycosis who underwent CSF
analysis were included for analysis. Patients were excluded if CSF
analysis was not performed, or if the patient had a known
diagnosis of CNS coccidioidal infection prior to presentation to
one of the above mentioned institution(s), or charts were miscoded.
Meningitis was defined as the presence of coccidioidal precipitin
(IgM) antibody, or CF (IgG) antibody in the CSF in accordance
with existing EORTC/MSG guidelines [9].
Clinical variables collected included demographic data, patient
symptoms and exam findings, serum coccidioidal antibody titers,
and CSF results. Neurologic abnormalities were defined as
headache, photophobia, focal deficits, seizures, neurologic abnor-
Table 1. Baseline characteristics of 58 patients with suspected coccidioidal meningitis who underwent CSF evaluation.
Found to have coccidioidal
meningitis (n = 14)
Patients without coccidioidal
meningitis (n = 44)
Age, median years (range) 49 (25–78) 41 (19–69)
Male sex 12 (86%) 37 (84%)
Ethnicity
Ethnicity
Hispanic 10 17
Caucasian 2 11
Black 0 10
Asian/Pacific Islander 1 5
Unknown 1 1
Immunosuppressed
HIV 7 16
CD4,200 6 14
Transplant 0 1
Immunosuppressive medications 0 2
Diabetes Mellitus 5 7
Concurrent coccidioidal infection*
Primary coccidioidal pneumonia 2 7
Chronic Pulmonary¥ 8 26
Joint/Bone 2 8
Cutaneous 0 15
Fungemia 1 2
Peritoneal disease 0 2
*Some patients had more than one type of coccidioidal infection.
¥Defined by positive sputum cultures or cavity for .6 months.
doi:10.1371/journal.pone.0064249.t001
Table 2. Clinical variables associated with CNS coccidioidomycosis.
Symptom Number with CNS infection (n=14) Number without CNS Infection (n =44)
Headache 14 18
Fever 5 13
Nuchal rigidity 3 3
Photophobia 2 3
Focal motor deficit 1 0
Focal sensory deficit 0 0
Recent seizures 0 2
Altered mental status 4 8
Papilledema 0 0
Abnormal CNS imaging 7 5
Abnormal visual fields 0 1
Ataxia 2 0
doi:10.1371/journal.pone.0064249.t002
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malities on examination or abnormal CNS radiographic studies.
The presence or absence of each of 21 signs and symptoms
(headache, fever, nuchal rigidity, photophobia, motor focal deficit,
sensory deficit, recent seizures, altered mental status, papilledema,
abnormal CNS imaging, gaze palsy, abnormal visual fields, facial
palsy, left/right arm palsy/drift, left/right leg palsy/drift, ataxia,
aphasia, abnormal sensation, and dysarthria) were abstracted from
patient charts (modified from [10]).
Mantel-Haenszel’s test was used to evaluate the association
between the presence of at least one sign or symptom and CNS
infection and Woolf’s test was applied to test for homogeneity of
odds ratios across institutions. P values ,0.05 were considered
statistically significant.
Results
Patients with coccidioidomycosis who did not undergo CSF
analysis were excluded. A total of 353 charts were reviewed, 249
with coccidioidomycosis. Of the reviewed charts, 58 coccidioido-
mycosis cases who underwent CSF analysis were included in this
study. A large number of patients were thus excluded due to a lack
of lumbar puncture given no clinical concern for meningitis at
time of physician evaluation. No statistically significant differences
were found in demographic or host risk factors between patient
groups with or without coccidioidal meningitis (p.0.05) (Table 1).
Nineteen patients were from northern California (UC Davis and
UCSF), 21 from southern California (UCSD and UCLA) and 18
from Texas (UT). All patients included had proven coccidioido-
mycosis in accordance with the Mycosis Study Group-European
Organization for the Research and Treatment of Cancer (MSG/
EORTC) criteria [9]. The patients were predominantly male
(84%) and Hispanic (47%). Other risk factors for coccidioidomy-
cosis included infection with the human immunodeficiency virus
(HIV) (41%), diabetes mellitus (21%) and receipt of immunosup-
pressive medications (4%). Interestingly, 17/58 (29.3%) patients
underwent CSF evaluation despite no signs or symptoms
attributable to CNS infection. Fourteen (24%) of the patients
were diagnosed with coccidioidal meningitis. All 14 patients with
meningitis had at least one symptom or sign related to CNS
disease (Table 2). Among the symptoms reported, headache was
the most common, occurring in 14/14 (100%) of patients with
meningitis and only 18/44 (41%) of those without meningitis
(Table 2). The presence of a headache was significantly associated
with meningitis (P,0.001). The odds ratio of meningitis for
patients with headaches to those without did not differ significantly
across the three study areas (P = 0.629) and was estimated as 14.53
[95% C.I. 2.47–85.44]. Thus, 0% of patients [95%
C.I. = 0224%] had CSF evidence of meningitis in the absence
of signs or symptoms. However, the presence of at least one
symptom or sign related to CNS disease had poor positive
predictive value and was not significantly associated with the
diagnosis of meningitis (P = 0.229). Odds ratios did not signifi-
cantly differ across the three study areas (P = 0.794).
Pooled estimates for the sensitivity, specificity, likelihood ratio
positive and likelihood ratio negative of 1) at least one CNS disease
sign or symptom and 2) headache alone as a predictors for
meningitis are provided in Table 3. Sensitivities were very high,
estimated as 1.00, indicating that all patients with meningitis
exhibited some sign or symptom of CNS disease but the low
specificities indicate that many patients without meningitis also
present with these symptoms. Using the pooled estimates for
sensitivity and specificity, we estimated the positive and negative
predictive values at prevalences of 0.15 and 0.3, which bounds the
range observed in this study for three study sites (Northern
California: 0.18 [3/17]; Southern California: 0.29 [6/21]; Texas:
0.25 [5/20]). Both the presence of at least one CNS disease sign or
symptom or headache alone, had high negative predictive values
(Table 4). The high negative predictive values indicate that
patients with meningitis rarely fail to exhibit symptoms.
A sub-group analysis of the 24 patients with HIV was
conducted. In this group 8 patients (33%) were ultimately
diagnosed with coccidioidal meningitis (6 with CD4,200 cells/
mL). All patients with HIV and coccidioidal meningitis exhibited
symptoms consistent with CNS infection (100% had headache)
suggesting that even in immunocompromised patients most
manifest symptoms consistent with CNS coccidioidomycosis.
Coccidioidal complement fixation titers exhibited considerable
variation between patients, and only 2 (3%) patients with
coccidioidal meningitis exhibited antibody titers ,1:16. Patients
without coccidioidal meningitis also exhibited a wide-range of
CF antibody titers (range 0 - 1:512) (Figure 1). No serum CF
titer cut-off was useful at distinguishing patients with vs. without
meningeal disease. Low titer coccidioidal CF antibody can be
detected in the CSF of patients even in the absence of
coccidioidal meningitis, however in our study coccidioidal CF
antibody in the CSF was found only in those with coccidioidal
meningitis (confirmation by concurrent changes in the CSF cell
count, protein, and glucose parameters). No patient given a
non-coccidioidal diagnosis had detectable coccidioidal antibody
in their CSF.
Discussion
Coccidioidomycosis is a common infection with a widely
variable presentation. Sixty percent of patients exposed to
Coccidioides spp. manifest no symptoms and are identified only
after exhibiting skin test positivity [11]. The remaining 40% of
patients exhibit disease ranging from subacute pulmonary
symptoms with fever, cough, and night sweats to disseminated
disease with meningitis. Due to concerns about missing occult
meningitis in patients with high CF titers (e.g., .1:16) or other
predisposing conditions, LPs are often performed even in the
absence of signs or symptoms referable to CNS infection.
However, this practice exposes patients to the risks and costs of
an invasive procedure with uncertain benefit.
Current IDSA coccidioidomycosis guidelines recommend CSF
analysis in patients who develop progressively severe or persistent
headaches, mental status changes or other meningeal signs [1] and
are silent on CSF examination in the asymptomatic patient. In the
authors’ experience, CSF examination is routinely performed on
patients with elevated coccidioidal CF titers, those with underlying
immunosuppression, or those with other risk factors favoring the
Table 3. Pooled estimates (95% confidence limits) for
sensitivity, specificity, likelihood ratio positive, likelihood ratio
negative for 1) at least 1 CNS disease sign or symptom and 2)
headache alone as predictors of meningitis.
At least 1 sign/
symptom Headache alone
Sensitivity 1.00 [0.77, 1.00] 1.00 [0.77, 1.00]
Specificity 0.25 [0.13, 0.40] 0.59 [0.43, 0.74]
Likelihood Ratio Positive 1.25 [0.99, 1.59] 2.30 [1.55, 3.42]
Likelihood Ratio Negative 0.33 [0.07, 1.59] 0.15 [0.03, 0.68]
doi:10.1371/journal.pone.0064249.t003
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development of disseminated disease (Filipino or of African
descent, etc) [12]. However, we found no benefit in conducting
LPs in patients with coccidioidomycosis who had no signs or
symptoms referable to CNS infection, irrespective of CF titer,
immune status, or ethnicity. Thus, our results suggest that routine
LP may not be required in the absence of symptoms referable to
CNS infection. Furthermore, because 2 of 14 patients with
meningitis had serum CF titers ,1:16, it is important to rule out
meningitis in patients with relevant signs or symptoms even if CF
antibody titers are low.
The decision to perform a lumbar puncture has important
therapeutic implications as unrecognized coccidioidal meningitis
has been associated with unfavorable outcomes [13]. Although our
results suggest an algorithmic approach to the care of patients with
coccidioidomycosis is unlikely to be helpful - our results do suggest
CSF analysis in the asymptomatic is often performed (29.3% of the
patients in our study).
Prior series of coccidioidal meningitis have not specifically
examined the frequency of symptoms attributable to CNS
infection, although such literature is generally concordant with
the current study. One prior study included patients with proven,
probable, and possible coccidioidal meningitis and found head-
ache in 77% of patients; no comment was made on the frequency
of asymptomatic patients ultimately diagnosed with CNS infection
[14]. Similar findings were reported by Mathisen et al among
patients diagnosed with coccidioidal meningitis in both 1980
(headache in 79%, N=31) and 2008 cohorts (77%, N=30),
however they likewise did not describe any asymptomatic patients
with CNS infection [15]. In another cohort, all 13 patients with
coccidioidal meningitis exhibited CNS symptoms consistent with
infection of the CNS [13]. These prior reports suggest that
coccidioidal meningitis in the absence of suggestive clinical signs or
symptoms is rare, consistent with our results.
Strengths of our analysis included its multi-centered nature and
availability of clinical data to confirm meningeal disease or not.
This is the largest attempt to refine the approach to evaluation for
coccidioidal meningitis. Limitations include the fact that the data
were collected retrospectively and patients with recurrent disease
were excluded. The number of HIV+ patients was small, and
larger series are needed to validate our results in immunosup-
pressed populations. In addition, because we included referral
centers, there may be a bias towards inclusion of patients with
more severe disease. It is possible that patients with asymptomatic
meningitis were excluded from inclusion due to a lack of CSF
analysis, however we believe this event is unlikely as disease
progression over time would have allowed for later diagnosis and it
therefore seems unlikely meaningful numbers of patients with
meningitis were excluded. Prospective evaluation of our findings
would provide additional evidence for a symptom-based approach
to management.
Additionally, our results examined patients only with a ‘‘new’’
diagnosis of coccidioidomycosis, and clinicians may encounter
patients diagnosed with coccidioidomycosis at other facilities with
little ancillary data available at the time of their evaluation. In this
circumstance, some clinicians would opt to perform CSF
examination prior to discontinuation of antifungal therapy. This
circumstance was not specifically evaluated in our study and
antifungal therapy may mask CNS symptoms with meningitis
presenting only after discontinuation of antimicrobial agents.
In summary we advocate for a careful history and physical
examination of patients with coccidioidomycosis rather than
automatic evaluation of the cerebrospinal fluid. Until larger
prospective databases are available to validate the current results,
we support a thoughtful and individualized approach to evaluating
the risk of dissemination and presenting symptomatology as a
guide to management decisions.
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Table 4. Positive and negative predictive values (95% confidence limits) for 1) at least 1 CNS disease sign or symptom and 2)
headache alone as predictors of meningitis for prevalences of 0.15 and 0.30.
At least 1 sign/symptom Headache only
Prevalence Positive Predictive Value Negative Predictive Value Positive Predictive Value Negative Predictive Value
0.15 0.19 [0.09, 0.33] 1 [0.73, 100]] 0.30 [0.14, 0.50] 1 [0.88, 1]
0.30 0.36 [0.23, 0.52] 1 [0.69, 100] 0.51 [0.33, 0.69] 1 [0.85, 1]
doi:10.1371/journal.pone.0064249.t004
Figure 1. Coccidioidal CF (IgG) serum antibody titers and
association with coccidioidal meningitis.
doi:10.1371/journal.pone.0064249.g001
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